购物车
- 全部删除
- 您的购物车当前为空
BIP-135 是一个高效、选择性的,ATP 竞争性的 GSK-3 抑制剂,对 GSK-3α 和 GSK-3β 作用的 IC50 值分别为 16 nM 和 21 nM。BIP 135 具有神经保护作用。
为众多的药物研发团队赋能,
让新药发现更简单!
BIP-135 是一个高效、选择性的,ATP 竞争性的 GSK-3 抑制剂,对 GSK-3α 和 GSK-3β 作用的 IC50 值分别为 16 nM 和 21 nM。BIP 135 具有神经保护作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 316 | 现货 | |
5 mg | ¥ 732 | 现货 | |
10 mg | ¥ 1,180 | 现货 | |
25 mg | ¥ 2,330 | 现货 | |
50 mg | ¥ 3,330 | 现货 | |
100 mg | ¥ 4,660 | 现货 | |
200 mg | ¥ 6,290 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 822 | 现货 |
产品描述 | BIP-135 is a potent and selective ATP-competitive GSK-3 inhibitor. With IC50s of 16 nM and 21 nM for GSK-3α and GSK-3β, respectively. BIP 135 exhibits neuroprotective effect[1]. |
靶点活性 | GSK-3α:16 nM, GSK-3β:21 nM |
体外活性 | BIP-135 (20 μM; 48 hours) is a superior neuroprotective agent in the model of oxidative stress[1]. BIP-135 (20-30 μM; 72 hours) increases the survival motor neuron (SMN) protein levels at a dose of 25 μM in human SMA fibroblasts. And the typical bell-shaped dose-response curve is observed due to some toxicity at higher concentrations[1]. |
体内活性 | BIP-135 (75 mg/kg; i.p.; daily; from postnatal day 0 to 21) prolongs the median survival time of Δ7 SMA KO mouse model of spinal muscular atrophy. And it does not appear to be toxic and was well-tolerated by the animals (no decrease in body weight)[1]. |
分子量 | 421.24 |
分子式 | C21H13BrN2O3 |
CAS No. | 941575-71-9 |
存储 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 56.7 mg/mL (134.6 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.